We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

DiaMedica's Type 2 Diabetes Antibody Shown to Increase Glucose Infusion Rate by 291%

Product News   Apr 21, 2011

 
DiaMedica's Type 2 Diabetes Antibody Shown to Increase Glucose Infusion Rate by 291%
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

BellBrook Labs Awarded Phase II Grant to Develop Drugs for Lupus and Related Autoimmune Diseases

Product News

BellBrook Labs has been awarded a $1.8 million Phase II SBIR grant for the treatment of lupus and other autoimmune diseases.

READ MORE

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Product News

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE